Growth Metrics

Oramed Pharmaceuticals (ORMP) Prepaid Assets (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Prepaid Assets readings, the most recent being $2.7 million for Q4 2025.

  • Quarterly Prepaid Assets rose 112.32% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2025, up 112.32% year-over-year, with the annual reading at $2.7 million for FY2025, 112.32% up from the prior year.
  • Prepaid Assets hit $2.7 million in Q4 2025 for Oramed Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.7 million in Q4 2025 and bottomed at $474000.0 in Q3 2024.
  • Average Prepaid Assets over 5 years is $1.2 million, with a median of $1.0 million recorded in 2022.
  • The largest annual shift saw Prepaid Assets soared 451.49% in 2021 before it tumbled 64.79% in 2024.
  • Oramed Pharmaceuticals' Prepaid Assets stood at $1.8 million in 2021, then dropped by 22.7% to $1.4 million in 2022, then plummeted by 61.34% to $537000.0 in 2023, then skyrocketed by 140.41% to $1.3 million in 2024, then skyrocketed by 112.32% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Prepaid Assets are $2.7 million (Q4 2025), $1.4 million (Q3 2025), and $1.1 million (Q2 2025).